Treatment of chronic hepatitis B: curren
β
Ruth Chin; Stephen Locarnini
π
Article
π
2003
π
John Wiley and Sons
π
English
β 222 KB
## Abstract The clinical management of chronic hepatitis B infection has entered a new era with the introduction and widespread use of oral nucleoside analogues such as lamivudine and nucleotides such as adefovir dipivoxil. From this, new challenges have now emerged in terms of preventing antiviral